ÂÜÀòÂÒÂ×

The Research Team at SAB Biotherapeutics is responsible for developing and optimizing cutting-edge immunotherapy solutions using fully human polyclonal antibodies. They conduct experimental research, evaluate clinical data, and produce antigens essential for treating diseases such as Covid-19, diabetes, organ transplant complications, and the flu.